Titan Pharmaceuticals
TTNP
#10596
Rank
S$7.86 M
Marketcap
S$5.91
Share price
-3.76%
Change (1 day)
16.29%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -S$3.69 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$6.04 Million, an increase over its 2023 earnings that were of -S$7.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$3.69 Million-38.95%
2024 -S$6.04 Million-15.5%
2023 -S$7.15 Million-45.43%
2022 -S$13.1 Million16.29%
2021 -S$11.27 Million-907.36%
2020 S$1.39 M-106.6%
2019 -S$21.12 Million82.4%
2018 -S$11.58 Million-36.93%
2017 -S$18.36 Million-378.62%
2016 S$6.58 M-145.53%
2015 -S$14.48 Million369.37%
2014 -S$3.09 Million-125.9%
2013 S$11.9 M-177.74%
2012 -S$15.32 Million13.59%
2011 -S$13.48 Million74.37%
2010 -S$7.74 Million3.61%
2009 -S$7.47 Million
2007 -S$23.66 Million12.08%
2006 -S$21.11 Million-28.65%
2005 -S$29.58 Million-10.03%
2004 -S$32.88 Million-6.08%
2003 -S$35.01 Million-14.76%
2002 -S$41.07 Million32.52%
2001 -S$30.99 Million27.55%
2000 -S$24.3 Million62.5%
1999 -S$14.96 Million4.04%
1998 -S$14.38 Million49.33%
1997 -S$9.63 Million-27.88%
1996 -S$13.35 Million13.04%
1995 -S$11.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.33 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.25 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-S$0.16 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$0.10 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.41 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA